ALVOW Alvotech Warrant
$0.17▼ -14.96%
Healthcare
Other
Volume 1.7K
Avg Volume (10D) –
Key Metrics & Fundamentals
Market Cap
–
P/E Ratio
–
Div Yield
–%
52W Range
0.17 - 0.20
% vs 50 MA
-42.68%
% vs 200 MA
–%
RSI-14
42.4
MACD Histogram
-0.0100
Beta (1Y vs SPY)
-0.83
Free Cash Flow
-$64.56M
Gross Rev
$105.77M
Gross Profit
$53.58M
EBITDA
-$40.14M
COGS
$52.20M
Operating Exp
$65.28M
Operating Income
-$11.71M
EBIT
-$11.71M
Pretax Income
-$66.76M
Net Income
-$66.82M
Price & Volume History
Loading chart…
Recent News
Alvotech's Manufacturing Progress, Simponi Launch Potential Support Recovery, UBS Says
MT Newswires · Oct 20, 2026 12:11 PM ET
Alvotech Says FDA Approves New Manufacturing Process for Simlandi; Shares Rise Pre-Bell
MT Newswires · Oct 20, 2026 5:33 AM ET
Alvotech shares jump premarket after FDA approves new Simlandi process
Investing.com · Oct 20, 2026 5:22 AM ET
Alvotech receives FDA approval for new SIMLANDI® manufacturing process that more than doubles output per batch
GlobeNewswire · Oct 20, 2026 4:30 AM ET
Alvotech Receives FDA Approval for New SIMLANDI® Manufacturing Process That More Than Doubles Output Per Batch
GlobeNewswire · Oct 20, 2026 4:30 AM ET
Alvotech Stock In Focus After Europe Filing For Eylea 8 Mg Copycat
Simply Wall St. · Oct 16, 2026 7:19 PM ET
Alvotech, Advanz seek EU nod for high-dose Eylea biosimilar
MT Newswires · Oct 14, 2026 6:16 AM ET
Alvotech and Advanz Pharma announce first known regulatory submission worldwide for proposed biosimilar to Eylea® 8 mg
GlobeNewswire · Oct 14, 2026 4:30 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ALVOW's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.